Budget 2026 to Boost Drug Testing Labs and Regulatory Staffing
The upcoming Union Budget is expected to announce new drug testing laboratories and increased regulatory manpower to strengthen India's pharmaceutical oversight amid global scrutiny.
Category : Search result: pharmaceutical regulation
Amit Shah Launches $50M Pharma Academy in Rajkot
Union Minister Amit Shah inaugurated the Pharmaceutical Academy for Global Excellence in Rajkot. The Indian Pharmaceutical Alliance commits $50 million to boost manufacturing skills.
Amit Shah Launches PAGE Pharma Academy in Ahmedabad
Union Home Minister Amit Shah inaugurated the Pharmaceutical Academy for Global Excellence in Ahmedabad, a $50 million industry-led skilling program to boost pharmaceutical manufacturing quality.
India's Healthcare System in Crisis: Regulatory Failure Exposed
A surge in deaths from contaminated drugs and Ayushman fraud reveals a broken regulatory system. India's private healthcare sector, providing 80% of services, operates without oversight. Read the full investigation.
Drugs sold as food in Telangana: DCA finds 9 cases
Telangana's drug regulator finds pharmaceutical firms illegally marketing medicines as 'nutraceuticals' to bypass safety checks, posing serious health risks. Read the full investigation.
Delhi extends deadline for school fee regulation panels
Delhi High Court grants schools more time to set up fee committees and submit hike proposals. The court refuses to stay the new fee regulation law, seeks response from DoE and LG. Next hearing on March 12.
Delhi HC: No Stay on New Private School Fee Law
Delhi High Court refuses to stay new fee regulation law for private schools but extends deadlines. Committees must be formed by Jan 20. Key details inside.
India Plans New Pharma Licence for Bulk Drugs to Boost Safety
India plans a major pharma licensing overhaul with a separate wholesale licence for bulk drugs and APIs to improve traceability and safety. This move follows global scrutiny over contaminated cough syrups and aims to regulate a $50-billion market.
India's New Pharma Licence Regime to Fix Accountability
India plans a new wholesale licensing system for bulk drugs and a supplier database to enhance traceability and accountability in its $50-billion pharmaceutical market, following global safety concerns.
Drug Inspection Data Kept Secret, Public Safety at Risk?
India's drug regulator CDSCO refuses to disclose risk-based inspection details under RTI, sparking debate on transparency vs. commercial interests. Experts warn this secrecy endangers public health.
India's Digital Regulation Gap: Impact on Consumers
With no law to regulate digital services, what does India's regulatory gap mean for competition and your digital rights? Mozilla explains the need for tailored rules.
Delhi Schools Get Jan 10 Deadline for Fee Panels
Delhi's Directorate of Education mandates all private schools to set up School Level Fee Regulation Committees by January 10, 2026. This historic move under a new law gives parents a direct say in fee hikes.
Delhi Govt Rolls Out New Fee Regulation for Private Schools
The Delhi government has introduced a new fee regulation framework for private schools, aiming to ensure transparency and prevent arbitrary hikes. Learn how this impacts parents and institutions.
Karnataka drug safety crisis due to inspector shortage
A critical shortage of drug inspectors in Karnataka has crippled regulatory oversight, exposing citizens to significant health risks. Read about the enforcement crisis and its implications.
Trump's Deal with 9 Pharma Firms to Cut US Drug Prices
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Odisha Pharma Summit 2025 garners Rs 7,043 crore proposals
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Govt Audits 700+ Cough Syrup Makers, Tests 19 Samples
Indian government intensifies scrutiny on pharmaceutical sector, auditing 700+ cough syrup manufacturers. Health Ministry reveals 19 drug samples collected for testing amid child safety concerns. Read the full report.
12 Pharma Firms Booked in UP Cough Syrup Smuggling Case
Uttar Pradesh government intensifies crackdown on cough syrup smuggling, registers cases against 12 pharmaceutical companies. Investigation reveals interstate smuggling network.
SC Suggests Aadhaar Age Verification for Online Content
Supreme Court proposes Aadhaar-based age verification for online content and autonomous regulatory body. Hearing cases involving YouTubers over obscenity allegations.
SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.
Sudeep Pharma IPO Allotment Status Today
Sudeep Pharma IPO allotment finalized today after massive 93.71x subscription. GMP at ₹87 signals 14.67% listing gain. Track your allotment status now!
Indian Pharma Pivots to Innovative Products: PHARMEXCIL
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma IPO Subscribed 94 Times
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Global Tenders for 65+ Patented Drugs in India
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Ramaswamy's net worth jumps 80% to $1.8 billion
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Aurobindo Pharma China Facility Targets Break-Even by FY26
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister's Directive to Pharma Industry
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US Trade Deal: $500B Target & Stock Gains
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly First Pharma to Reach $1 Trillion Market Cap
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
Smallcap Pharma Stock Gains 10% Despite Market Sell-Off
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Page 1 of 4